Search Results - Europe*

Environmental causes of obesity sociocultural, built environment and economic factors /

Get full text
Series

Race in genetics and medicine

Table of Contents: “…Contents: Questions about race -- Fundamentals of DNA and the genome -- Human genome sequence -- DNA sequence variation -- Three essential features of human genome diversity -- Expected nucleotide diversity -- STR analysis -- Relationships among human populations -- Major long-range human migrations -- Definition of race -- Allocation of individuals to genetic clusters -- Principal pathway of ethanol metabolism -- Allele frequencies at ALDH2 locus -- European ancestry and diabetes risk.…”
Get full text
Series

The peopling of the Americas new insights from genetic studies /

Table of Contents: “…-- Two different founding populations colonized the Americas -- Linguistic evidence -- Genetic background -- mtDNA lineages in native Americans -- mtDNA haplogroup frequencies in Siberia and the Americas -- Population history of Amerindian haplogroups -- Haplogroup X in North and Central America -- Prehistoric European migration to North America -- History and diversification of circumarctic peoples -- Ancient vs. modern population diversity -- Colonization of the Caribbean -- Y chromosome haplogroup frequencies in the Americas -- Y chromosome haplogroup frequencies in native Siberians -- Y chromosome SNP haplotype network -- Migration models based on Y chromosome data.…”
Get full text
Series

History and geography of human genetic diversity II by Cavalli-Sforza, L. L. (Luigi Luca), 1922-

Get full text
Series

Predicting TSE transmission

Get full text
Series

Methicillin resistant S. aureus and other resistances

Table of Contents: “…Contents: Antibiotic resistance in hospitals -- Antibiotic resistance in the community -- The pre-antibiotic era -- Penicillin -- Tuberculosis -- Streptomycin -- Streptococcus pneumoniae -- Multidrug resistant pneumococci -- Staphylococcus aureus -- Spread of MRSA -- European and worldwide distribution of MRSA -- Treatment of MRSA -- The benefits of antibiotics -- The extent of bacterial resistance in the UK -- Causes of resistance -- Antibiotic classes -- The pyramids for antimicrobial use and selection for antimicrobial resistance -- The threat -- Why no new antibiotics?…”
Get full text
Series

Beta-lactamases clinical impact and epidemiology /

Table of Contents: “…-- Active site of the TEM-1 beta-lactamase -- Amino acid substitutions -- European spread of CTX-M beta-lactamases -- ESBL activity -- Summary of OXA b-lactamases in Acinetobacter baumannii -- Emergence of the NDM-1 beta-lactamase.…”
Get full text
Series

Public policy to reduce antibiotic resistance

Get full text
Series

Conventional and automated diagnostic methods

Table of Contents: “…CLSI -- MIC determination by E-test -- MICs of multiple antibiotics for the same bacterial strain -- Testing E. coli -- Interpretation of susceptibility tests -- Defining susceptibility and resistance -- European Committee on Antimicrobial Susceptibility testing (EUCAST) -- EUCAST MIC breakpoints -- Clinical breakpoints -- Microbiological breakpoints -- Establishing breakpoints -- Automating antibiotic susceptibility testing -- Vitek 2 AST system -- Advanced expert system -- Interpretive reading: the limits -- The future.…”
Get full text
Series

Controlling antibiotic resistance in the hospital environment

Table of Contents: “…Contents: Epidemiology of antibiotic resistant organisms (ARO) in hospitalised patients -- European Antimicrobial Resistance Surveillance System (EARSS) -- MRSA, E. faecium and E. coli isolates in different countries -- Resistance to vancomycin -- Extended spectrum beta-lactamases -- Significant bacteraemias by organism -- Why control ARO in hospitals? …”
Get full text
Series

Can HPV testing be the sole primary cervical screening modality?

Table of Contents: “…Contents: Cases of cervical cancer in the UK -- Potential role of HPV testing in cervical screening -- Baseline results of HPV testing in European and North American screening studies -- HPV positivity by age -- Cytology sensitivity and positivity -- HPV sensitivity and positivity -- Double-testing studies -- Randomized trials -- Long-term follow-up of HPV testing: results from the Hammersmith study -- Proposed new screening algorithm -- HPV typing -- mRNA testing -- Other potential adjunctive tests -- Potential future screening algorithm.…”
Get full text
Series

Substructure searching, similarity calculations and fingerprints

Get full text
Series

Ring searching and aromaticity detection

Get full text
Series

Chemogenomics

Get full text
Series

Latent autoimmune diabetes in adults

Get full text
Series

Urinary proteomics in kidney and cardiovascular disease

Table of Contents: “…Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy.…”
Get full text
Series (Clinical proteomics)
Series (Kidney in health and disease)

Vesicular release of transmitter at active zones

Get full text
Series

Genetic variation in North America

Table of Contents: “…Contents: Ethical & social implications of genetic research in indigenous communities -- A multidisciplinary approach to infer evolutionary history -- Genetic variation studies in Native Americans -- Ancient DNA research to bypass genomic effects of European colonization -- Non-indigenous admixture in Native Americans.…”
Get full text
Series

Metabolomics a brief introduction, part 1 of 2 /

Get full text
Series

Data sharing and data standards for metabolomics where are we now? /

Get full text
Series